These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25984566)

  • 1. Putting Tuberculosis (TB) To Rest: Transformation of the Sleep Aid, Ambien, and "Anagrams" Generated Potent Antituberculosis Agents.
    Moraski GC; Miller PA; Bailey MA; Ollinger J; Parish T; Boshoff HI; Cho S; Anderson JR; Mulugeta S; Franzblau SG; Miller MJ
    ACS Infect Dis; 2015 Feb; 1(2):85-90. PubMed ID: 25984566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity.
    Moraski GC; Markley LD; Hipskind PA; Boshoff H; Cho S; Franzblau SG; Miller MJ
    ACS Med Chem Lett; 2011 Jun; 2(6):466-470. PubMed ID: 21691438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrofuranyl Methyl Piperazines as New Anti-TB Agents: Identification, Validation, Medicinal Chemistry, and PK Studies.
    Yempalla KR; Munagala G; Singh S; Magotra A; Kumar S; Rajput VS; Bharate SS; Tikoo M; Singh GD; Khan IA; Vishwakarma RA; Singh PP
    ACS Med Chem Lett; 2015 Oct; 6(10):1041-6. PubMed ID: 26487909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imidazo[1,2-A]Pyridine: Potent Biological Activity, SAR and Docking Investigations (2017-2022).
    Narayan A; Patel S; Baile SB; Jain S; Sharma S
    Infect Disord Drug Targets; 2024; 24(8):e200324228067. PubMed ID: 38509674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and antimycobacterial activity of imidazo[1,5-
    Marner M; Kulhanek N; Eichberg J; Hardes K; Molin MD; Rybniker J; Kirchner M; Schäberle TF; Göttlich R
    RSC Med Chem; 2024 May; 15(5):1746-1750. PubMed ID: 38784461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage takeover and the host-bacilli interplay during tuberculosis.
    Hussain Bhat K; Mukhopadhyay S
    Future Microbiol; 2015; 10(5):853-72. PubMed ID: 26000654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfiram and Copper Ions Kill Mycobacterium tuberculosis in a Synergistic Manner.
    Dalecki AG; Haeili M; Shah S; Speer A; Niederweis M; Kutsch O; Wolschendorf F
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4835-44. PubMed ID: 26033731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cytochrome bd-type quinol oxidase is important for survival of Mycobacterium smegmatis under peroxide and antibiotic-induced stress.
    Lu P; Heineke MH; Koul A; Andries K; Cook GM; Lill H; van Spanning R; Bald D
    Sci Rep; 2015 May; 5():10333. PubMed ID: 26015371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phylogenetic analysis of vitamin B12-related metabolism in Mycobacterium tuberculosis.
    Young DB; Comas I; de Carvalho LP
    Front Mol Biosci; 2015; 2():6. PubMed ID: 25988174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives.
    Via LE; Savic R; Weiner DM; Zimmerman MD; Prideaux B; Irwin SM; Lyon E; O'Brien P; Gopal P; Eum S; Lee M; Lanoix JP; Dutta NK; Shim T; Cho JS; Kim W; Karakousis PC; Lenaerts A; Nuermberger E; Barry CE; Dartois V
    ACS Infect Dis; 2015 May; 1(5):203-214. PubMed ID: 26086040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface hydrolysis of sphingomyelin by the outer membrane protein Rv0888 supports replication of Mycobacterium tuberculosis in macrophages.
    Speer A; Sun J; Danilchanka O; Meikle V; Rowland JL; Walter K; Buck BR; Pavlenok M; Hölscher C; Ehrt S; Niederweis M
    Mol Microbiol; 2015 Sep; 97(5):881-97. PubMed ID: 26036301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic Analysis of Drug-Resistant Mycobacteria: Co-Evolution of Copper and INH Resistance.
    Chen Y; Yang F; Sun Z; Wang Q; Mi K; Deng H
    PLoS One; 2015; 10(6):e0127788. PubMed ID: 26035302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic and dose-response relationships of antituberculosis drugs: recommendations and standards for industry and academia.
    Gumbo T; Angulo-Barturen I; Ferrer-Bazaga S
    J Infect Dis; 2015 Jun; 211 Suppl 3():S96-S106. PubMed ID: 26009618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments of imidazo[1,2-
    Samanta S; Kumar S; Aratikatla EK; Ghorpade SR; Singh V
    RSC Med Chem; 2023 Apr; 14(4):644-657. PubMed ID: 37122538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic approaches to potent heterocyclic inhibitors of tuberculosis: A decade review.
    Dasmahapatra U; Chanda K
    Front Pharmacol; 2022; 13():1021216. PubMed ID: 36386156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses and studies of deuterated Imdiazo[1,2-a]pyridine-3-carboxamides with potent anti-tuberculosis activity and improved metabolic properties.
    Liu R; Marshall K; Ma R; Lien Thi Pham K; Shetye G; Liu Z; Cho S; Jeong H; Franzblau SG; Moraski GC; Miller MJ
    Bioorg Chem; 2022 Nov; 128():106074. PubMed ID: 35987188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of QcrB Inhibition as a Measure of Antitubercular Activity with Machine Learning Protocols.
    Khan AA; Poojary SS; Bhave KK; Nandan SR; Iyer KR; Coutinho EC
    ACS Omega; 2022 May; 7(21):18094-18102. PubMed ID: 35664614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of novel indole-2-carboxamides for growth inhibition of
    Alsayed SSR; Lun S; Bailey AW; Suri A; Huang CC; Mocerino M; Payne A; Sredni ST; Bishai WR; Gunosewoyo H
    RSC Adv; 2021 Apr; 11(26):15497-15511. PubMed ID: 35481189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the cytochrome bc
    Wani MA; Dhaked DK
    Mol Divers; 2022 Oct; 26(5):2949-2965. PubMed ID: 34762234
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.